Small cell cervical neuroendocrine tumor [Serviksin küçük hücreli nöroendokrin tümörü]

Basit Öğe Kaydı
dc.contributor.authorTerek M.C.
dc.contributor.authorHurşitoglu B.S.
dc.contributor.authorSözbilen M.
dc.contributor.authorDikmen Y.
dc.contributor.authorZekioglu O.
dc.date.accessioned2019-10-26T21:54:18Z
dc.date.available2019-10-26T21:54:18Z
dc.date.issued2012
dc.departmentEge Üniversitesien_US
dc.description.abstractSmall cell neuroendokrin tümörs of cervix is 2-5% of all cervical malignancies constituting a small portion that exhibit highyl agressive behavior and early metastasis. No clear consensus exists regarding the therapy besides the implementation of multimodal treatment. The role of radical hysterectomy is not known clearly but combined radiochemotherapy is the key treatment combination. As a chemotherapeutic cysplatin-etoposide or vincristin-adriamisin-cyclophosphamide combinations are initiated. Five years survival rate varies between %0-30.en_US
dc.identifier.endpage92en_US
dc.identifier.issn1301-8841
dc.identifier.issn1301-8841en_US
dc.identifier.issue3en_US
dc.identifier.scopusqualityN/Aen_US
dc.identifier.startpage90en_US
dc.identifier.urihttps://hdl.handle.net/11454/18930
dc.identifier.volume15en_US
dc.indekslendigikaynakScopusen_US
dc.language.isoenen_US
dc.publisherGunes Kitap Kirtasiyeen_US
dc.relation.ispartofTurk Jinekolojik Onkoloji Dergisien_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectCervixen_US
dc.subjectPrognosisen_US
dc.subjectSmall cell neuroendocrin tumoren_US
dc.titleSmall cell cervical neuroendocrine tumor [Serviksin küçük hücreli nöroendokrin tümörü]en_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

Scopus İndeksli Yayınlar Koleksiyonu